Physical Deconditioning in COVID-19 Positive Patients and Non-Specific Low Back Pain

Low Back Pain, Mechanical Clinical Trial

— Phydel  

Official title:

Physical Deconditioning and Non-Specific Low Back Pain: the PHYDEL Study. A Prospective Study in a COVID-19 Positive Cohort

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04990518
• Other study ID #: 2020-01994
• Status: Terminated
• Start date: November 5, 2022
• Est. completion date: November 5, 2022

Study information

• Verified date: November 2022
• Source: University Hospital, Geneva
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to take advantage of cohorts of patients followed for Coronavirus Disease 2019 (COVID19) expected to present poor physical fitness as the consequence of COVID19 to explore the relationship between physical fitness and low back pain (LBP). Level of physical fitness will be measured at baseline and incidence and intensity of LBP will be recoreded over 1 year.

Description:

Non-specific low back pain (LBP) is the worldwide number one cause for disease related years lived with disability. It is frequently assumed that a low physical fitness is a major risk factor for acute LBP as well as a factor for chronic LBP. However only few prospective observational study have been conducted. The purpose of this study is to take advantage of cohorts of patients followed for Coronavirus Disease 2019 (COVID19) expected to present poor physical fitness as the consequence of COVID19 and assessing level of physical fitness and both incidence and intensity of LBP over a 1-year period. The study aims to determine if a poor physical health, as measured by 6 minutes walk test (6MWT) and 30''seconds sit to stand test (30''STS), is a risk factor for LBP occurrence and for chronic LBP Secondary objectives aim to explore the respective weight of physical factors (i.e. physical fitness, BMI, smoking, physical activities) and psychological factors (i.e. depression, anxiety, catastrophism, fear-avoidance) on the occurrence and severity of LBP. According to the literature, we expect that in the physically healthy population, 15% will developed back pain; whereas in the population in poor physical health the incidence at 1 year will be 30%. If alpha error is set at 0.05 then 236 patients are required to have a 80% chance to confirm our hypothesis. In order to account for drop out, and considering that the risk of drop out is high in this type of non-interventional study 350 persons will be recruited. Note that this amount of persons should yield approximately 70 persons with low back pain, which allow up to 7 independent variable in a logistic or cox regression. This is based on the rule of at least 10 events (low back pain) per variable.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 350
• Est. completion date: November 5, 2022
• Est. primary completion date: November 5, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Age > 18 years, <65 years old
• Confirmed or supected COVID19 test
• Informed Consent as documented by signature

Exclusion Criteria:

• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
• Previous enrolment into the current study.
• Any comorbidity which could impact on the physical test (6-minutes walking test), e.g hip or knee osteoarthritis, polyneuropathy, symptomatic coronary heart disease.

Related Conditions & MeSH terms

• Back Pain
• Low Back Pain
• Low Back Pain, Mechanical

Locations

Country	Name	City	State
Switzerland	Geneva University Hospital	Geneva

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

References & Publications (9)

Bohannon RW, Crouch R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract. 2017 Apr;23(2):377-381. doi: 10.1111/jep.12629. Epub 2016 Sep 4. Review. — View Citation

Buchbinder R, Batterham R, Elsworth G, Dionne CE, Irvin E, Osborne RH. A validity-driven approach to the understanding of the personal and societal burden of low back pain: development of a conceptual and measurement model. Arthritis Res Ther. 2011;13(5): — View Citation

Choi BK, Verbeek JH, Tam WW, Jiang JY. Exercises for prevention of recurrences of low-back pain. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006555. doi: 10.1002/14651858.CD006555.pub2. Review. — View Citation

Dionne CE, Dunn KM, Croft PR, Nachemson AL, Buchbinder R, Walker BF, Wyatt M, Cassidy JD, Rossignol M, Leboeuf-Yde C, Hartvigsen J, Leino-Arjas P, Latza U, Reis S, Gil Del Real MT, Kovacs FM, Oberg B, Cedraschi C, Bouter LM, Koes BW, Picavet HS, van Tulde — View Citation

Genevay S, Marty M, Courvoisier DS, Foltz V, Mahieu G, Demoulin C, Fontana AG, Norberg M, de Goumoëns P, Cedraschi C, Rozenberg S; Section Rachisde la Société Française de Rhumatologie. Validity of the French version of the Core Outcome Measures Index for — View Citation

Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, Woolf A, Vos T, Buchbinder R. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012 Jun;64(6):2028-37. doi: 10.1002/art.34347. Epub 2012 Jan 9. Review. — View Citation

Kongsted A, Hestbæk L, Kent P. How can latent trajectories of back pain be translated into defined subgroups? BMC Musculoskelet Disord. 2017 Jul 3;18(1):285. doi: 10.1186/s12891-017-1644-8. — View Citation

Maetzel A, Li L. The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol. 2002 Jan;16(1):23-30. Review. — View Citation

Verbunt JA, Smeets RJ, Wittink HM. Cause or effect? Deconditioning and chronic low back pain. Pain. 2010 Jun;149(3):428-430. doi: 10.1016/j.pain.2010.01.020. Epub 2010 Feb 12. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	1-year incidence of LBP	Influence of baseline physical fitness on the number of participant with at least 1 episode of Low Back Pain	1 year
Primary	1-year incidence of chronic LBP	Influence of baseline physical fitness on the number of participant with at least 3 months of LBP most of the days	1 year
Secondary	Severity of LBP according to Pain trajectories	Influence of baseline physical fitness on 1 year pain trajectories recorded at the end of the study	at least 3 months during the last year
Secondary	Severity of LBP according to multiaxial evaluation	Influence of baseline physical fitness on Severity measured with COMI, multi-axial PRO specific for LBP	1 year
Secondary	Severity of LBP according to treatment use	Influence of baseline physical fitness on the number of medical and paramedical appointements during the pain period	1 year
Secondary	Influence of depression on 1-year incidence of LBP	Influence of depression as measured with HADS on the incidence of LBP	1 year
Secondary	Influence of anxiety on 1-year incidence of LBP	Influence of anxiety as measured with HADS on the incidence of LBP	1 year
Secondary	Influence of catastrophism on 1-year incidence of LBP	Influence of catastrpphism as measured with PCS on the incidence of LBP	1 year
Secondary	Influence of fear-avoidance beliefs on 1-year incidence of LBP	Influence of fear-avoidance beliefs as measured with FABQ on the incidence of LBP	1 year
Secondary	Influence of self-efficacy on 1-year incidence of LBP	Influence of self-efficacy as measured with PSEQ-2 on the incidence of LBP	1 year
Secondary	Influence of depression on 1-year incidence of chronic LBP	Influence of depression as measured with HADS on the incidence of people with LBP for more than 3 months	1 year
Secondary	Influence of anxiety on 1-year incidence of chronic LBP	Influence of anxiety as measured with HADS on the incidence of people with LBP for more than 3 months	1 year
Secondary	Influence of catastrophism on 1-year incidence of chronic LBP	Influence of catastrophisms measured with PCS on the incidence of people with LBP for more than 3 months	1 year
Secondary	Influence of fear-avoidance beliefs on 1-year incidence of chronic LBP	Influence of fear-avoidance beliefs measured with FABQ on the incidence of people with LBP for more than 3 months	1 year
Secondary	Influence of self-efficacy on 1-year incidence of chronic LBP	Influence of self-efficacy measured with PSEQ-2 on the incidence of people with LBP for more than 3 months	1 year
Secondary	Influence of depression on severity of LBP accroding to pain trajectories	Influence of depression as measured by HADS on 1 year pain trajectories recorded at the end of the study	1 year
Secondary	Influence of anxiety on severity of LBP accroding to pain trajectories	Influence of anxiety as measured by HADS on 1 year pain trajectories recorded at the end of the study	1 year
Secondary	Influence of catastrophism on severity of LBP accroding to pain trajectories	Influence of catastrophism as measured by PCS on 1 year pain trajectories recorded at the end of the study	1 year
Secondary	Influence of fear-avoidance beliefs on severity of LBP accroding to pain trajectories	Influence of fear-avoidance beliefs as measured with FABQ on 1 year pain trajectories recorded at the end of the study	1 year
Secondary	Influence of self-efficacy on severity of LBP accroding to pain trajectories	Influence of self-efficacy as measured with PSEQ-2 on 1 year pain trajectories recorded at the end of the study	1 year
Secondary	Influence of depression on severity of LBP assessed with a multiaxial tool	Influence of depression as measured by HADS on severity as assessed with COMI, multi-axial PRO specific for LBP	1 year
Secondary	Influence of anxiety on severity of LBP assessed with a multiaxial tool	Influence of anxiety as measured by HADS on severity as assessed with COMI, multi-axial PRO specific for LBP	1 year
Secondary	Influence of catastrophism on severity of LBP assessed with a multiaxial tool	Influence of catastrophism as measured by PCS on severity as assessed with COMI, multi-axial PRO specific for LBP	1 year
Secondary	Influence of fear-avoidance beliefs on severity of LBP assessed with a multiaxial tool	Influence of fear-avoidance beliefs as measured by FABQ on severity as assessed with COMI, multi-axial PRO specific for LBP	1 year
Secondary	Influence of self-efficacy on severity of LBP assessed with a multiaxial tool	Influence of self-efficacy as measured by PSEQ-2 on severity as assessed with COMI, multi-axial PRO specific for LBP	1 year
Secondary	Influence of depression on severity of LBP according to treatment use	Influence of depression as measured by HADS on the number of medical and paramedical appointements during the pain period	1 year
Secondary	Influence of anxiety on severity of LBP according to treatment use	Influence of anxiety as measured by HADS on the number of medical and paramedical appointements during the pain period	1 year
Secondary	Influence of catastrophism on severity of LBP according to treatment use	Influence of catastrophism as measured by PCS on the number of medical and paramedical appointements during the pain period	1 year
Secondary	Influence of fear-avoidance beliefs on severity of LBP according to treatment use	Influence of fear-avoidance beliefs measured by FABQ on the number of medical and paramedical appointements during the pain period	1 year
Secondary	Influence of self-efficacy on severity of LBP according to treatment use	Influence of self-efficacy measured by PSEQ-2 on the number of medical and paramedical appointements during the pain period	1 year
Secondary	Impact of regular physical activity on LBP episode	Studing the impact of the intensity of physical activity during the previous month on the length and the intensity (COMI) of LBP episode.	1 year
Secondary	Impact of regular physical activity on chronicity	Studing the impact of the intensity of physical activity during the previous month on the risk of chronicity (3 months of pain most of the day)	1 year